Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Impact of perioperative course during cardiac surgery on outcomes in patients 80 years and older

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Specialist training for cardiothoracic surgery in the Nordic countries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The significance of bicuspid aortic valve after surgery for acute type A aortic dissection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Malperfusion in acute type A aortic dissection: An update from the Nordic Consortium for Acute Type A Aortic Dissection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Fascicular heart blocks and risk of adverse cardiovascular outcomes: results from a large primary care population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Return to work after COVID-19 infection - A Danish nationwide registry study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: Oral anticoagulation with vitamin K antagonists is recommended after mechanical heart valve replacement. However, data regarding the association between the quality of vitamin K antagonist treatment and the risk of complications are sparse.

METHODS: Patients undergoing mechanical heart valve replacement (1997-2012) with available data on international normalized ratio values were identified in Danish registries. The quality of vitamin K antagonist treatment between discharge after valve replacement and 6 months postdischarge (ie, index) was assessed as time in therapeutic range (TTR) ≥70% or <70% reflecting the percentage of time in therapeutic international normalized ratio interval. Patients were followed from index until occurrence of an outcome of interest (ie, thromboembolism and bleeding), death, or end of study (December 31, 2012), whichever came first. The risk of outcomes according to quality of vitamin K antagonist treatment was estimated with multivariable Cox regression.

RESULTS: In total, 659 patients undergoing mechanical heart valve replacement were included in the study. Median number of international normalized ratio measurements in the 6-month period after surgery was 13 (interquartile range, 8-19). Median TTR was 54.9% (interquartile range, 39.0%-72.9%) and 29.1% of patients had a TTR ≥70%. Median follow-up was 6.1 years. The risk of thromboembolism was significantly lower in the group with TTR ≥70% compared with TTR <70% (hazard ratio, 0.44; 95% confidence interval, 0.22-0.85), whereas no significant difference concerning risk of bleeding among groups was found (hazard ratio, 0.63; 95% confidence interval 0.36-1.08).

CONCLUSIONS: In patients undergoing mechanical heart valve replacement, TTR <70% in the 6-month period after surgery was associated with an increased risk of thromboembolic events but not bleeding compared with TTR ≥70%.

OriginalsprogEngelsk
TidsskriftJournal of Thoracic and Cardiovascular Surgery
Vol/bind159
Udgave nummer1
Sider (fra-til)74-83.e4
ISSN0022-5223
DOI
StatusUdgivet - 1 jan. 2020

Bibliografisk note

Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

ID: 58229759